The international law firm Freshfields Bruckhaus Deringer ('Freshfields') has advised Cheplapharm Arzneimittel GmbH ('Cheplapharm') on an agreement with Astellas Pharma Inc., a Japan based pharmaceutical company, to purchase products rights for five products in certain countries (Europe, Russia, Commonwealth of Independent States, Asia) through an asset deal.

Cheplapharm is a pharmaceutical company headquartered in Greifswald, Germany, offering branded and niche products in more than 120 countries worldwide. It has been one of the fastest-growing pharmaceutical companies in Europe.

Freshfields advised on all legal cross-border aspects of the asset purchase agreement. The Freshfields core team comprised partners Jochen Dieselhorst and Lars Meyer as well as Johannes Kater, Elisabeth Wulf and Christoph Becherer (all Corporate); partner Christian Ruoff and Andrea Strackerjan advised on tax topics.

Cheplapharm's inhouse legal team included Legal Counsel Dr. Jan Klumb and Junior Legal Counsel Anees Ahmed.